Recombinant Mouse ITGaE Protein，His

ITGaE, or integrin alpha E, is a crucial protein that plays a significant role in various biological processes, including cell adhesion, immune response, and tissue development. Research into ITGaE has gained momentum due to its involvement in several pathological conditions, such as cancer metastasis, autoimmune diseases, and infectious diseases, making it a potential target for therapeutic intervention. The integrin family of proteins, including ITGaE, functions as receptors that mediate the interaction between cells and the extracellular matrix (ECM), influencing cellular behavior and gene expression. The heterodimeric nature of integrins, where ITGaE pairs with its beta counterpart, further complicates their functional dynamics, necessitating in-depth studies of their structure and interactions. Advances in recombinant protein technology have enabled researchers to produce ITGaE in manageable quantities, facilitating investigations into its molecular structure and functional roles. By understanding the mechanisms through which ITGaE operates, scientists aim to uncover its contributions to cell signaling pathways and potential implications in therapeutic development. The reconstitution of ITGaE and its binding partners in vitro is crucial for delineating its specific functions under various physiological and pathological conditions. As ongoing research sheds light on the complexities of integrin biology, ITGaE continues to emerge as a key player in therapeutic strategies aimed at manipulating immune responses and targeting cancer progression. This evolving interest highlights the significance of ITGaE in biomedical research and its potential to influence future clinical applications.